Bruce Randazzo, M.D., Ph.D., FAAD
Vice President, Clinical Development
Bruce joined Anaptys with more than 25 years of experience as a physician and pharmaceutical executive. He has had hands on experience in all phases of drug development across multiple therapeutic areas, including psoriasis and other dermatologic diseases, rheumatoid arthritis, diabetes, inflammatory bowel disease, opioid induced constipation, superficial and systemic fungal infections. Bruce has designed and executed many successful clinical development programs, regulatory submissions and approvals in both adult and pediatric indications for companies including Pfizer and Janssen. Bruce has also held the distinguished position of clinical associate professor in the Associate Faculty, Department of Dermatology, clinical associate professor in the Associated Faculty, Department of Dermatology, University of Pennsylvania. Bruce received his M.D. from SUNY at Stony Brook University, NY in Medicine and Experimental Pathology.